Adam Crystal - President, R&D at Tango Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D
Issuer Symbol
TNGX on Nasdaq
All Insider Reports
All Insider Reports

Adam Crystal - trading volume in the past year for Tango Therapeutics, Inc.

Holdings reported by Adam Crystal for Tango Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 112,622 $1,689,330 $15.00 05 Mar 2026 Direct
Stock Option (Right to Buy) 284,760 02 Feb 2026 Direct Common Stock

Transactions reported by Adam Crystal for Tango Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.